moxifloxacin has been researched along with Abdominal Abscess in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hampel, B; Lippert, H; Muehlhofer, E; Reimnitz, P; Weiss, G | 1 |
| Goldstein, EJ | 1 |
| Karpov, OI; Strekachev, AIu; Zaĭtsev, AA | 1 |
| Chuah, SK; Gollapudi, S; Thadepalli, H | 1 |
| Choudhri, S; Herrington, J; Malangoni, MA; Pertel, P; Song, J | 1 |
| Delesen, H; Kubitza, D; Rink, AD; Stass, H; Vestweber, KH | 1 |
1 review(s) available for moxifloxacin and Abdominal Abscess
| Article | Year |
|---|---|
[New approaches to antibacterial therapy of infections in the surgical practice].
Topics: Abdominal Abscess; Aza Compounds; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Cross Infection; Ertapenem; Fluoroquinolones; Humans; Lactams; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Surgical Wound Infection | 2003 |
3 trial(s) available for moxifloxacin and Abdominal Abscess
| Article | Year |
|---|---|
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).
Topics: Abdominal Abscess; Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Appendicitis; Aza Compounds; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Peritonitis; Prospective Studies; Quinolines | 2009 |
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
Topics: Abdominal Abscess; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendicitis; Aza Compounds; Bacterial Infections; Cross Infection; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Intestinal Perforation; Male; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Quinolines; Safety; Stomach Rupture; Treatment Outcome | 2006 |
Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.
Topics: Abdominal Abscess; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Infective Agents; Area Under Curve; Aza Compounds; Body Fluids; Bradycardia; Drainage; Female; Fluoroquinolones; Half-Life; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Moxifloxacin; Quinolines; Time Factors; Tissue Distribution; Tomography, X-Ray Computed | 2008 |
2 other study(ies) available for moxifloxacin and Abdominal Abscess
| Article | Year |
|---|---|
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones | 2002 |
Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
Topics: Abdominal Abscess; Animals; Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Disease Models, Animal; Fluoroquinolones; Injections, Subcutaneous; Levofloxacin; Male; Metronidazole; Mice; Moxifloxacin; Ofloxacin; Quinolines | 2004 |